Cannabis, referred to as marijuana under federal law is currently classified as a Schedule I controlled substance under the Controlled Substances Act (CSA). This is the highest restriction classification in the federal scheduling system, placing cannabis alongside heroin and above cocaine and methamphetamine in terms of federal legal status.
This classification has significant implications for research, banking, employment, federal benefits, and the relationship between state-legal cannabis markets and federal law. This guide explains what Schedule I means, how the scheduling system works, how cannabis compares to other scheduled substances, and what the ongoing rescheduling discussions mean in 2026.
What Schedule Drug Is Weed? The Short Answer
| Quick Answer
Cannabis (marijuana) is a Schedule I controlled substance under the federal Controlled Substances Act. Schedule I is the most restrictive federal drug classification it means the federal government considers cannabis to have no currently accepted medical use and a high potential for abuse. This federal status exists regardless of state legalization laws. |
How the Federal Drug Scheduling System Works
The Controlled Substances Act, passed in 1970, created a five-tier classification system (Schedule I through Schedule V) for controlled substances. Placement in a schedule is based on three criteria:
- The drug’s potential for abuse
- Whether the drug has a currently accepted medical use in the United States
- Whether the drug may lead to physical or psychological dependence
The DEA (Drug Enforcement Administration) and the FDA (Food and Drug Administration) share responsibility for scheduling decisions, with the FDA making the scientific and medical determination and the DEA making the final scheduling decision.
| Schedule | Criteria | Examples |
|---|---|---|
| Schedule I | High abuse potential; no currently accepted medical use; lack of accepted safety | Cannabis (marijuana), heroin, LSD, psilocybin, ecstasy (MDMA) |
| Schedule II | High abuse potential; currently accepted medical use with severe restrictions; high dependence potential | Cocaine (medical use), methamphetamine (Desoxyn), oxycodone, fentanyl, Adderall |
| Schedule III | Moderate abuse potential; accepted medical use; moderate to low physical dependence | Ketamine, anabolic steroids, testosterone, buprenorphine, Tylenol with codeine |
| Schedule IV | Low abuse potential relative to Schedule III; accepted medical use | Xanax (alprazolam), Valium (diazepam), Ambien (zolpidem), tramadol |
| Schedule V | Lowest abuse potential of controlled substances; accepted medical use | Cough preparations with less than 200mg codeine, pregabalin (Lyrica) |
Why Cannabis Is Schedule I And Why That’s Contested
The Schedule I classification for cannabis dates to 1970, when the CSA was passed. At that time, a presidential commission (the Shafer Commission) was convened to evaluate cannabis’s scheduling and recommended against placing it in Schedule I, suggesting decriminalization. The Nixon administration rejected the commission’s recommendation and cannabis was placed in Schedule I, where it has remained for over 50 years.
The Schedule I designation is contested by researchers, medical organisations, and advocates for two primary reasons:
The ‘No Accepted Medical Use’ Problem
Schedule I requires that a substance have ‘no currently accepted medical use.’ Cannabis-derived pharmaceutical products most notably Epidiolex (a CBD-based medication for epilepsy) and Marinol (synthetic THC for nausea and appetite) are FDA-approved and classified in lower schedules. This creates a contradiction: cannabis-derived pharmaceuticals have accepted medical use, but the cannabis plant itself is maintained as Schedule I.
More than 30 states have medical cannabis programs precisely because they recognise medical applications. The federal ‘no accepted medical use’ determination contradicts the clinical judgement of thousands of physicians and the legislative decisions of most US states.
The Research Catch-22
Schedule I classification makes cannabis research significantly more difficult. Researchers must obtain special DEA licenses, use cannabis from approved sources (historically a single DEA-approved facility at the University of Mississippi), and navigate extensive bureaucratic requirements that don’t apply to Schedule II or III substances. This limits the research that could establish medical applications which in turn is cited as justification for maintaining the Schedule I classification. Critics describe this as a circular barrier that prevents the science needed to change the classification.
The 2024 DEA Rescheduling Proposal: What Would Schedule III Mean?
In 2024, the DEA proposed rescheduling cannabis from Schedule I to Schedule III a significant change that would still maintain federal cannabis regulation but would acknowledge medical use and represent a meaningful shift in federal policy.
What Schedule III Would and Would Not Change
| Issue | Schedule I (Current) | Schedule III (Proposed) |
|---|---|---|
| Accepted medical use | Federal government says: none | Federal government would acknowledge: yes |
| Research requirements | Highly restricted special DEA license, limited sources | Significantly reduced barriers |
| Cannabis business banking | Banks largely avoid cannabis (federal crime) | Banking access improved federal crime removed for businesses in legal states |
| Federal tax code Section 280E | Applies cannabis businesses cannot deduct ordinary business expenses | No longer applies major financial relief for cannabis industry |
| Individual possession/sale | Still federally illegal without Schedule III prescription pathway | Still federally illegal without approved medical pathway |
| State-legal cannabis markets | Technically federal law violations | Clearer federal tolerance but state-legal sales still not fully federally authorized |
| Cross-state transport | Federal crime | Still federal crime |
| Employment/federal benefits | Federal employees and security clearance holders still subject to federal law | Some improvement but federal workplace policies still apply |
The key point: rescheduling to Schedule III would not federally legalize cannabis for adult recreational use. It would reduce research barriers, potentially resolve the cannabis banking problem, remove the punishing 280E tax burden from cannabis businesses, and formally acknowledge medical use at the federal level. But consumers in legal states would not see a dramatic change to their day-to-day experience.
Federal vs State Law: The Current Tension
The most confusing aspect of cannabis law in the United States is the coexistence of state-legal markets and federal prohibition. Understanding how this works and doesn’t work is important for anyone who uses cannabis legally at the state level.
The Supremacy Clause and Why States Can Legalize
Under the US Constitution’s Supremacy Clause, federal law generally takes precedence over state law when they conflict. Cannabis’s Schedule I status is federal law. So how can states legalize it?
The answer is the anti-commandeering doctrine the federal government cannot compel state governments to enforce federal drug laws. States can choose not to prohibit cannabis under state law, creating legal state markets. The federal government chooses not to use federal resources to enforce cannabis prohibition in legal states, establishing an ongoing policy of non-interference (established through the Obama-era Cole Memo and maintained informally since).
This means state-legal cannabis exists in a tolerated space not because federal law permits it, but because the federal government currently chooses not to enforce federal law against state-compliant activity.
Where Federal Law Still Applies in Legal States
Even in states with adult-use cannabis, federal law creates real restrictions:
- Federal land and parks: National parks, national forests, federal office buildings, and military installations are federal property where cannabis is illegal regardless of state law
- Federal employees: Government employees, security clearance holders, and employees in federally regulated industries (aviation, transportation) can lose employment or clearances for cannabis use
- Cross-state transport: Driving or flying with cannabis from one state to another is a federal crime the most important practical rule for consumers in legal states
- Cannabis banking: Many banks avoid serving cannabis businesses due to federal law, though this is improving as federal enforcement posture evolves
- Federal housing: Public housing residents can be subject to cannabis restrictions under federal housing regulations
Our complete guide to US cannabis laws for beginners and our states where weed is legal guide cover the full national picture of what is and isn’t legal in each state.
What This Means for Cannabis Users in Vermont
Vermont has adult-use cannabis legal for adults 21 and older, regulated by the Vermont Cannabis Control Board. Vermont’s state-legal market operates under the same federal tolerance framework as every other legal state. The Schedule I classification has not prevented Vermont’s market from operating, but it does mean:
- Cannabis purchased at Vermont dispensaries cannot be transported across state lines
- Federal employees in Vermont are still subject to federal drug-free workplace policies
- Cannabis use on federal land in Vermont (national forests, etc.) remains federally illegal
- Vermont’s dispensaries still face some banking complications due to federal law
At Juana’s Garden in Montpelier, Vermont, we operate under Vermont’s adult-use cannabis regulations for adults 21 and older. Browse our current menu, check our deals, and explore our education hub for more legal and informational guides.
Authoritative Resources on Federal Cannabis Scheduling
Drug Enforcement Administration dea.gov Official DEA controlled substance scheduling information
US Department of Justice justice.gov Federal cannabis enforcement policy
Vermont Cannabis Control Board ccb.vermont.gov Vermont’s adult-use regulatory body
Frequently Asked Questions: Cannabis Federal Scheduling
What schedule drug is weed?
Cannabis (referred to as marijuana under federal law) is currently a Schedule I controlled substance under the federal Controlled Substances Act. Schedule I is the most restrictive classification, designating substances with high abuse potential, no currently accepted medical use, and lack of accepted safety under medical supervision. This federal classification has been in place since 1970, despite the majority of US states now having legal cannabis programs.
Is weed a Schedule I or Schedule III drug?
As of 2026, cannabis remains a Schedule I drug under federal law. The DEA proposed rescheduling it to Schedule III in 2024, following an HHS recommendation. The rescheduling process has been ongoing. If rescheduling to Schedule III is completed, cannabis would be formally acknowledged as having medical applications a significant change from Schedule I’s ‘no accepted medical use’ designation. Schedule III status would not federally legalize recreational cannabis but would reduce research barriers, remove the 280E tax burden from cannabis businesses, and improve banking access.
Does federal Schedule I status mean cannabis is illegal everywhere?
Federal Schedule I status means cannabis is illegal under federal law everywhere in the United States. However, states can choose not to enforce state-level cannabis prohibition and more than half have done so, creating legal state markets. The federal government has maintained a policy of not interfering with state-compliant cannabis businesses and users in legal states. This creates the current situation where cannabis is simultaneously federally illegal and state-legal in many jurisdictions. The most practically important federal rule that applies to users in all states: cannabis cannot be transported across state lines. For which states have legal cannabis, see our states where weed is legal guide.
Does buying cannabis at a Vermont dispensary violate federal law? Technically, under the federal Controlled Substances Act, purchasing cannabis is a violation of federal law. However, the federal government’s longstanding policy has been to defer to state law for state-compliant transactions in legal states. Adults 21 and older purchasing cannabis from licensed dispensaries like Juana’s Garden in Montpelier, Vermont are operating within Vermont’s legal framework under established federal non-enforcement policy. The most important practical rule: cannabis purchased in Vermont must remain in Vermont. Join our Amigos Rewards program and check our community events calendar.
Final Thoughts
Cannabis remains a Schedule I controlled substance under federal law in 2026 the most restrictive federal classification, placing it above cocaine and methamphetamine in terms of federal legal status despite the reality that over half of US states have legal cannabis programs. The proposed rescheduling to Schedule III, if completed, would mark a significant shift in federal acknowledgement of medical applications and would have meaningful practical effects on the cannabis industry but would not federally legalize recreational cannabis.
For cannabis users in legal states like Vermont, the Schedule I classification creates specific practical rules no cross-state transport, restrictions on federal land, and federal employment considerations while the day-to-day state-legal market continues to operate under federal non-enforcement policy. Our US cannabis laws beginner guide covers how state and federal law interact in more depth. And Juana’s Garden in Montpelier is open to Vermont adults 21 and older.
This article is for educational and informational purposes only and does not constitute legal advice. Federal cannabis law may change; always verify current federal and state rules through official sources. Juana’s Garden operates in Montpelier, Vermont, under Vermont Cannabis Control Board regulations. All purchases require valid ID confirming age 21 or older.
